199 related articles for article (PubMed ID: 20175035)
1. Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma.
Imbeaud S; Ladeiro Y; Zucman-Rossi J
Semin Liver Dis; 2010 Feb; 30(1):75-86. PubMed ID: 20175035
[TBL] [Abstract][Full Text] [Related]
2. Molecular classification of hepatocellular carcinoma.
Zucman-Rossi J
Dig Liver Dis; 2010 Jul; 42 Suppl 3():S235-41. PubMed ID: 20547309
[TBL] [Abstract][Full Text] [Related]
3. Comparative and integrative functional genomics of HCC.
Lee JS; Thorgeirsson SS
Oncogene; 2006 Jun; 25(27):3801-9. PubMed ID: 16799621
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
[TBL] [Abstract][Full Text] [Related]
6. High-dimensional biology to comprehend hepatocellular carcinoma.
Vivekanandan P; Singh OV
Expert Rev Proteomics; 2008 Feb; 5(1):45-60. PubMed ID: 18282123
[TBL] [Abstract][Full Text] [Related]
7. [miRNAs in cancer: the case of liver tumors].
Ladeiro Y; Zucman-Rossi J
Med Sci (Paris); 2009 May; 25(5):467-72. PubMed ID: 19480827
[TBL] [Abstract][Full Text] [Related]
8. Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness.
Tang Z; Qin L; Wang X; Zhou G; Liao Y; Weng Y; Jiang X; Lin Z; Liu K; Ye S
Chin Med J (Engl); 1998 Apr; 111(4):313-8. PubMed ID: 10374394
[TBL] [Abstract][Full Text] [Related]
9. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
10. Molecular classification of hepatocellular carcinoma anno 2011.
van Malenstein H; van Pelt J; Verslype C
Eur J Cancer; 2011 Aug; 47(12):1789-97. PubMed ID: 21612914
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling.
Lemmer ER; Friedman SL; Llovet JM
Semin Liver Dis; 2006 Nov; 26(4):373-84. PubMed ID: 17051451
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and molecular genetic alterations in hepatocellular carcinoma.
Lau SH; Guan XY
Acta Pharmacol Sin; 2005 Jun; 26(6):659-65. PubMed ID: 15916730
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma.
Jia D; Wei L; Guo W; Zha R; Bao M; Chen Z; Zhao Y; Ge C; Zhao F; Chen T; Yao M; Li J; Wang H; Gu J; He X
Hepatology; 2011 Oct; 54(4):1227-36. PubMed ID: 21688285
[TBL] [Abstract][Full Text] [Related]
14. HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma.
Wu X; Jia HL; Wang YF; Ren N; Ye QH; Sun HC; Wang L; Liu YK; Tang ZY; Qin LX
Oncogene; 2006 Mar; 25(12):1832-40. PubMed ID: 16261160
[TBL] [Abstract][Full Text] [Related]
15. Genomics and signaling pathways in hepatocellular carcinoma.
Villanueva A; Newell P; Chiang DY; Friedman SL; Llovet JM
Semin Liver Dis; 2007 Feb; 27(1):55-76. PubMed ID: 17295177
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
[TBL] [Abstract][Full Text] [Related]
17. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
Yeo W; Wong N; Wong WL; Lai PB; Zhong S; Johnson PJ
Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049
[TBL] [Abstract][Full Text] [Related]
18. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
19. Discovery of differentially expressed genes related to histological subtype of hepatocellular carcinoma.
Lee D; Choi SW; Kim M; Park JH; Kim M; Kim J; Lee IB
Biotechnol Prog; 2003; 19(3):1011-5. PubMed ID: 12790669
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
